Icariside II alleviates ischemic retinopathy by modulating microglia and promoting vessel integrity
Ischemic retinopathies (IRs) are vision-threatening diseases that affect a substantial amount of people. The current treatment options for IRs have side effects and are unable to prevent disease progression. It is therefore worthwhile to consider alternative treatments that could be safer and more e...
Main Authors: | Dan Yan, Qian Wu, Xiuchun Li, Qian Chen, Caihong Huang, Jiaoyue Hu, Zuguo Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-05-01
|
Series: | Journal of Functional Foods |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S175646462300110X |
Similar Items
-
Comparative Pharmacokinetics Study of Icariin and Icariside II in Rats
by: Tao Cheng, et al.
Published: (2015-12-01) -
Icariside II: Anticancer Potential and Molecular Targets in Solid Cancers
by: Fei Xu, et al.
Published: (2021-04-01) -
Distinguished Functions of Microglia in the Two Stages of Oxygen-Induced Retinopathy: A Novel Target in the Treatment of Ischemic Retinopathy
by: Ziyi Zhou, et al.
Published: (2022-10-01) -
Synthesis and Biological Evaluation of Novel Alkyl Amine Substituted Icariside II Derivatives as Potential Anticancer Agents
by: Tong Wu, et al.
Published: (2018-08-01) -
Pharmacological mechanism and therapeutic efficacy of Icariside II in the treatment of acute ischemic stroke: a systematic review and network pharmacological analysis
by: Xu Wang, et al.
Published: (2022-09-01)